Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2022.1098003 Immunology Correction Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese Shi Dian-Chun 1 2 3 † Feng Shao-Zhen 1 2 † Zhong Zhong 1 2 Cai Lu 1 2 Wang Meng 1 2 Fu Dong-Ying 1 2 Yu Xue-Qing 1 2 3 Li Ming 1 2 3 * 1 Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China 2 NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China 3 Division of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Ming Li, liming33@mail.sysu.edu.cn

†These authors have contributed equally to this work and share first authorship

This article was submitted to Autoimmune and Autoinflammatory Disorders: Autoimmune Disorders, a section of the journal Frontiers in Immunology

 24 11 2022 2022 13 1098003 14 11 2022 15 11 2022 Copyright © 2022 Shi, Feng, Zhong, Cai, Wang, Fu, Yu and Li 2022 Shi, Feng, Zhong, Cai, Wang, Fu, Yu and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese. By Shi D-C, Feng S-Z, Zhong Z, Cai L, Wang M, Fu D-Y, Yu X-Q, Li M. (2022) Front Immunol. 13:973169. doi: 10.3389/fimmu.2022.973169. IgA nephropathy complement factor B case-control study alternative pathway polymorphism

In the published article, there was an error regarding the affiliations for all authors. As well as having affiliation 1, they should also have “2NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China”.

The author Ming Li should also have “3Division of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.